Iranian Red Crescent Medical Journal

Published by: Kowsar

No Evidence for Association Between Norepinephrine Transporter-3081 (A/T) Polymorphism and Attention Deficit Hyperactivity Disorder in Iranian Population

Mohammad Reza Eslami Amirabadi 1 , Rozita Davari-Ashtiani 3 , Mojgan Khademi 3 , Sepideh RajeziEsfahani 1 , Babak Emamalizadeh 2 , Abolfazl Movafagh 2 , Fariba Arabgol 3 , Said Sadr 3 , Hossein Darvish 2 , * and Katayoon Razjouyan 3 , *
Authors Information
1 Behavioral Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Department of Psychiatry, Imam Hosein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Corresponding Authors:
Article information
  • Iranian Red Crescent Medical Journal: July 01, 2015, 17 (7); e22996
  • Published Online: July 23, 2015
  • Article Type: Research Article
  • Received: August 25, 2014
  • Revised: September 9, 2014
  • Accepted: November 9, 2014
  • DOI: 10.5812/ircmj.229961v2

To Cite: Eslami Amirabadi M R, Davari-Ashtiani R, Khademi M, RajeziEsfahani S, Emamalizadeh B, et al. No Evidence for Association Between Norepinephrine Transporter-3081 (A/T) Polymorphism and Attention Deficit Hyperactivity Disorder in Iranian Population, Iran Red Crescent Med J. 2015 ; 17(7):e22996. doi: 10.5812/ircmj.229961v2.

Abstract
Copyright © 2015, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Diagnostic and statistical manual-text revision (DSM-IV-TRim, 2000). 2000;
  • 2. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007; 164(6): 942-8[DOI][PubMed]
  • 3. Rowland AS, Lesesne CA, Abramowitz AJ. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view. Ment Retard Dev Disabil Res Rev. 2002; 8(3): 162-70[DOI][PubMed]
  • 4. Waldman ID, Rhee SH. Hyperactivity and attention disorders of childhood. 2002; : 290-335
  • 5. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005; 57(11): 1313-23[DOI][PubMed]
  • 6. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry. 2006; 11(10): 934-53[DOI][PubMed]
  • 7. Schimmelmann BG, Friedel S, Christiansen H, Dempfle A, Hinney A, Hebebrand J. [Genetic findings in Attention-Deficit and Hyperactivity Disorder (ADHD)]. Z Kinder Jugendpsychiatr Psychother. 2006; 34(6): 425-33[DOI][PubMed]
  • 8. Albayrak O, Friedel S, Schimmelmann BG, Hinney A, Hebebrand J. Genetic aspects in attention-deficit/hyperactivity disorder. J Neural Transm. 2008; 115(2): 305-15[DOI][PubMed]
  • 9. Gamo NJ, Wang M, Arnsten AF. Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine D1 receptors. J Am Acad Child Adolesc Psychiatry. 2010; 49(10): 1011-23[DOI][PubMed]
  • 10. Vikas M, Chandrasekaran R. A case of obsessive-compulsive disorder by proxy. Gen Hosp Psychiatry. 2011; 33(3): 303 e5-6[DOI][PubMed]
  • 11. Seneca N, Gulyas B, Varrone A, Schou M, Airaksinen A, Tauscher J, et al. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2. Psychopharmacology (Berl). 2006; 188(1): 119-27[DOI][PubMed]
  • 12. Bobb AJ, Addington AM, Sidransky E, Gornick MC, Lerch JP, Greenstein DK, et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet. 2005; 134B(1): 67-72[DOI][PubMed]
  • 13. Kim BN, Kim JW, Hong SB, Cho SC, Shin MS, Yoo HJ. Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorder. Behav Brain Funct. 2010; 6: 57[DOI][PubMed]
  • 14. Kim JW, Biederman J, McGrath CL, Doyle AE, Mick E, Fagerness J, et al. Further evidence of association between two NET single-nucleotide polymorphisms with ADHD. Mol Psychiatry. 2008; 13(6): 624-30[DOI][PubMed]
  • 15. Retz W, Rosler M, Kissling C, Wiemann S, Hunnerkopf R, Coogan A, et al. Norepinephrine transporter and catecholamine-O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults. J Neural Transm. 2008; 115(2): 323-9[DOI][PubMed]
  • 16. Joung Y, Kim CH, Moon J, Jang WS, Yang J, Shin D, et al. Association studies of− 3081 (A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2010; 153(2): 691-4
  • 17. Xu X, Knight J, Brookes K, Mill J, Sham P, Craig I, et al. DNA pooling analysis of 21 norepinephrine transporter gene SNPs with attention deficit hyperactivity disorder: no evidence for association. Am J Med Genet B Neuropsychiatr Genet. 2005; 134B(1): 115-8[DOI][PubMed]
  • 18. Lasky-Su J, Neale BM, Franke B, Anney RJ, Zhou K, Maller JB, et al. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B(8): 1345-54[DOI][PubMed]
  • 19. Kim CH, Hahn MK, Joung Y, Anderson SL, Steele AH, Mazei-Robinson MS, et al. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci U S A. 2006; 103(50): 19164-9[DOI][PubMed]
  • 20. Bauermeister JJ, Shrout PE, Chavez L, Rubio-Stipec M, Ramirez R, Padilla L, et al. ADHD and gender: are risks and sequela of ADHD the same for boys and girls? J Child Psychol Psychiatry. 2007; 48(8): 831-9[DOI][PubMed]
  • 21. Nezu A, Nezu C. A practical guide to conducting randomized controlled trials for psychosocial interventions. 2008;
  • 22. Hummer TA, Kronenberger WG, Wang Y, Dunn DW, Mosier KM, Kalnin AJ, et al. Executive functioning characteristics associated with ADHD comorbidity in adolescents with disruptive behavior disorders. J Abnorm Child Psychol. 2011; 39(1): 11-9[DOI][PubMed]
  • 23. Rosler M, Retz W, Retz-Junginger P, Hengesch G, Schneider M, Supprian T, et al. Prevalence of attention deficit-/hyperactivity disorder (ADHD) and comorbid disorders in young male prison inmates. Eur Arch Psychiatry Clin Neurosci. 2004; 254(6): 365-71[DOI][PubMed]
  • 24. Brook U, Boaz M. Attention deficit and hyperactivity disorder (ADHD) and learning disabilities (LD): adolescents perspective. Patient Educ Couns. 2005; 58(2): 187-91[DOI][PubMed]
  • 25. Nikolas MA, Burt SA. Genetic and environmental influences on ADHD symptom dimensions of inattention and hyperactivity: a meta-analysis. J Abnorm Psychol. 2010; 119(1): 1-17[DOI][PubMed]
  • 26. Gizer IR, Ficks C, Waldman ID. Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 2009; 126(1): 51-90[DOI][PubMed]
  • 27. Barr CL, Kroft J, Feng Y, Wigg K, Roberts W, Malone M, et al. The norepinephrine transporter gene and attention-deficit hyperactivity disorder. Am J Med Genet. 2002; 114(3): 255-9[PubMed]
  • 28. McEvoy B, Hawi Z, Fitzgerald M, Gill M. No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population. Am J Med Genet. 2002; 114(6): 665-6[DOI][PubMed]
  • 29. Guan L, Wang B, Chen Y, Yang L, Li J, Qian Q, et al. A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population. Mol Psychiatry. 2009; 14(5): 546-54[DOI][PubMed]
  • 30. Biederman J, Kim JW, Doyle AE, Mick E, Fagerness J, Smoller JW, et al. Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study. Am J Med Genet B Neuropsychiatr Genet. 2008; 147B(8): 1511-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments